Start New York, LLC

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Bladder cancer

Running trials

• Recruiting

  Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

  NCT07484022· Phase 1· Generate Biomedicines· Source

  Contact: Camilita Goberdhan

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting